Inhibition of antiviral CTL responses by virus-infected cells: Line item veto (cells) revisited

Virology

Volumn 272, Issue 2, 2000, Pages 237-243

  Rich, Robert F ^a   Green, William R ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE SUBPOPULATION; VIRUS CELL INTERACTION; VIRUS INFECTION;

EID: 0034608832     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0388     Document Type: Article

References (6)

1. Fink P. J., Shimonkevitz R. P., Bevan M. J. Veto cells. Annu. Rev. Immunol. 6:1988;115-137.
2. George J. F., Thomas J. M. The molecular mechanisms of veto mediated regulation of alloresponsiveness. J. Mol. Med. 77:1999;519-526.
3. + dendritic cells (DC) veto cells? The role of CD8 on DC in DC development and in the regulation of CD4 and CD8 T cell responses. Int. Immunol. 9:1997;1061-1064.
4. b lymphocytes inhibit the secondary in vitro cytotoxic T-lymphocyte response of primed responder cells to AKR/Gross murine leukemia virus-induced tumor cell stimulation. J. Virol. 70:1996;402-414.
5. + antiviral T cells by viral antigen-positive veto cells. J. Virol. 73:1999;3826-3834.
6. Villunger A., Egle A., Marschitz I., Kos M., Bock G., Ludwig H., Geley S., Kofler R., Greil R. Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: A potential mechanism of tumor-induced suppression of immune surveillance. Blood. 90:1997;12-20.